Fig. 1From: Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatmentThe role of γ-tocotrienol and statins in attenuating 3-hydroxy-3methyl-glutaryl-coenzyme A (HMGCoA) reductase activity and downstream progression of the mevalonate synthesis pathwayBack to article page